Experimental procedure aims to shrink untreatable childhood tumors
NCT ID NCT07136571
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study planned to test a procedure called transarterial embolization in children aged 2-18 with incurable soft tissue sarcomas. The goal was to block blood flow to tumors using tiny particles, potentially slowing growth or easing symptoms. However, the trial was withdrawn before any participants were enrolled, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bland particles (Embozene Color-Advanced Microspheres)
- What this could lead to
- If successful, this approach could offer a palliative option to shrink tumors and improve quality of life for children with incurable sarcomas.
- What could go wrong
- The trial was withdrawn before enrolling any participants, so no data exists. The approach is experimental and only targets certain tumors; benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental pill SHY-ONC6 takes on Hard-to-Treat cancers
- New cocktail of four drugs targets tough sarcomas in kids
- Could a shorter radiation zap before surgery be just as good for sarcoma patients?
- New drug combo shows promise for Hard-to-Treat sarcomas
- New hope for sarcoma patients: immunotherapy plus chemo shows promise
- Gene signature may forecast chemo response in sarcoma patients